NCT04715308

Brief Summary

The outcomes of patients who undergo radical surgery for locally advanced and recurrent rectal cancer have improved vastly, but there is a lack of emphasis on the quality-of-life outcomes of these patients. This study will assess the patient experience of having a stoma for urinary diversion as part of surgery for advanced pelvic malignancy. This will be assessed at regular intervals both before and after surgery with the goal of increasing awareness of patient beliefs and concerns with regards to their stomas and to devise interventions that will improve their quality-of-life.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2020

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2020

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

January 14, 2021

Completed
6 days until next milestone

First Posted

Study publicly available on registry

January 20, 2021

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2021

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2022

Completed
Last Updated

February 10, 2021

Status Verified

February 1, 2021

Enrollment Period

1 year

First QC Date

January 14, 2021

Last Update Submit

February 6, 2021

Conditions

Keywords

Rectal cancerLocally advanced and recurrent rectal cancerAdvanced pelvic cancerUrinary diversion for rectal cancerQuality of life

Outcome Measures

Primary Outcomes (2)

  • To determine the 30-day complication rate of urinary diversion/reconstruction following pelvic exenteration

    Morbidity of urinary diversion/reconstruction

    2 years

  • To assess the impact of urinary diversion/reconstruction subtypes on quality-of-life

    Patient-reported outcomes assessing their quality-of-life

    Before surgery and at 1, 3, 6, 9 and 12 months respectively

Secondary Outcomes (2)

  • To assess the longer-term complications associated with urinary diversion/reconstruction

    1 month - 12 months

  • To measure the rate of reintervention for complications associated with urinary diversion/reconstruction

    12 months

Interventions

The formation of a stoma to divert urine to the skin because of the need to resect the bladder as part of surgery for advanced pelvic malignancy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Cohort of patients who are undergoing surgery for locally advanced or recurrent rectal cancer and are undergoing a urinary diversion or reconstruction.

You may qualify if:

  • Histologically-proven advanced rectal cancer
  • Has undergone urinary diversion/reconstruction
  • Aged 18 years or older
  • Able and willing to give written, informed consent
  • Able to access email/internet

You may not qualify if:

  • Strong evidence of metastatic or peritoneal disease
  • Palliative exenteration
  • Non-rectal origin of primary tumour
  • Colonic obstruction
  • Inability to answer online questionnaire

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St. Vincent's Hospital

Dublin, D4, Ireland

RECRUITING

MeSH Terms

Conditions

Patient SatisfactionPatient ParticipationRectal Neoplasms

Interventions

Urinary Diversion

Condition Hierarchy (Ancestors)

Treatment Adherence and ComplianceHealth BehaviorBehaviorPatient Acceptance of Health CareColorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesIntestinal DiseasesRectal Diseases

Intervention Hierarchy (Ancestors)

Urologic Surgical ProceduresUrogenital Surgical ProceduresSurgical Procedures, Operative

Central Study Contacts

Matthew Fahy, MB

CONTACT

Michael Kelly, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor Des C Winter, Consultant Gastronitestinal Surgeon

Study Record Dates

First Submitted

January 14, 2021

First Posted

January 20, 2021

Study Start

December 1, 2020

Primary Completion

December 1, 2021

Study Completion

March 1, 2022

Last Updated

February 10, 2021

Record last verified: 2021-02

Data Sharing

IPD Sharing
Will not share

No individual patient date other than their responses to the questionnaire will be collected or shared.

Locations